The Indian pharmaceutical industry has emerged as one of the fastest-growing sectors globally, driven by increasing healthcare demands, technological advancements, and supportive government policies. Within this dynamic landscape, third party pharma manufacturing—also known as contract manufacturing—has become a highly preferred business model for pharma companies seeking cost efficiency and scalability.